Acute Immune-Mediated Thrombocytopenia due to Oxaliplatin and Irinotecan Therapy
We describe a case of a 63-year-old woman with advanced colon cancer and liver metastases who was treated with fluorouracil, leucovorin, and oxaliplatin (FOLFOX) and cetuximab chemotherapy. She tolerated 13 cycles of chemotherapy without any significant hematological side effects, but after the 14th...
Saved in:
Main Authors: | Eric L. Tam, Padma L. Draksharam, Jennifer A. Park, Gurinder S. Sidhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Oncological Medicine |
Online Access: | http://dx.doi.org/10.1155/2019/4314797 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synergistic Effects of Simvastatin and Irinotecan against Colon Cancer Cells with or without Irinotecan Resistance
by: Hyun Joo Jang, et al.
Published: (2016-01-01) -
Acute Brucellosis Presenting with Bleeding Tendency due to Isolated Severe Thrombocytopenia
by: M. Aon, et al.
Published: (2018-01-01) -
Irinotecan Plus S-1 Followed by Hepatectomy for a Patient with Initially Unresectable Colorectal Liver Metastases, Who Showed Severe Drug Rash with Oxaliplatin Plus 5-FU and Leucovorin (FOLFOX)
by: Hiroyuki Komori, et al.
Published: (2014-01-01) -
A Case of Primary Refractory Immune Thrombocytopenia: Challenges in Choice of Therapies
by: Hanyin Wang, et al.
Published: (2018-01-01) -
Azithromycin-Induced Thrombocytopenia: A Rare Etiology of Drug-Induced Immune Thrombocytopenia
by: Muhammad Umer Butt, et al.
Published: (2019-01-01)